A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs. [electronic resource]
Producer: 19981027Description: 429-34 p. digitalISSN:- 1053-0770
- Adrenergic alpha-Agonists -- administration & dosage
- Adrenergic alpha-Antagonists -- administration & dosage
- Animals
- Blood Flow Velocity -- drug effects
- Blood Pressure -- drug effects
- Cardiac Output -- drug effects
- Consciousness
- Coronary Circulation -- drug effects
- Coronary Vessels -- drug effects
- Dogs
- Drug Interactions
- Heart Rate -- drug effects
- Hemodynamics -- drug effects
- Hypnotics and Sedatives -- administration & dosage
- Imidazoles -- administration & dosage
- Injections, Intravenous
- Medetomidine
- Prospective Studies
- Quinolizines -- administration & dosage
- Random Allocation
- Time Factors
- Vascular Resistance -- drug effects
- Vasoconstrictor Agents -- pharmacology
- Ventricular Function, Left -- drug effects
- Ventricular Pressure -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.